Anvisa publishes GGMED Management Report

Anvisa has published the GGMED Management Report, highlighting advances in drug regulation in Brazil, emphasizing the importance of human capital and strategies to improve processes.

The document shows record drug registrations, reflecting efficiency and commitment to innovation policies. It also discusses the expansion of regulatory collaboration, the challenges of speeding up analyses and technological modernization, pointing to future strategies for tackling regulatory challenges. Read more here

If you need more regulatory information for your sunscreens, ELS can help you with our wide range of services for your products.

Please do not hesitate to contact your local ELS consultant or via email

Contact us

We will contact you as soon as possible.